Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 8.36% |
AMGEN INC. | AMGN | 6.11% |
GILEAD SCIENCES, INC. | GILD | 4.56% |
VERTEX PHARMACEUTICALS | VRTX | 4.01% |
REGENERON PHARMACEUTICALS | REGN | 3.98% |
CORTEVA INC | CTVA | 2.90% |
ALNYLAM PHARMACEUTICALS | ALNY | 2.69% |
ASTRAZENECA PLC ADR | AZN | 2.64% |
BIOGEN IDEC, INC. | BIIB | 2.48% |
MODERNA INC | MRNA | 2.41% |
ILLUMINA INC | ILMN | 2.18% |
UNITED THERAPEUTICS CORP | UTHR | 1.79% |
NATERA INC | NTRA | 1.74% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.70% |
VAXCYTE INC | PCVX | 1.68% |
VIATRIS INC | VTRS | 1.67% |
EXACT SCIENCES | EXAS | 1.65% |
INSMED INC | INSM | 1.59% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.55% |
SAREPTA THERAPEU | SRPT | 1.53% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.52% |
INCYTE CORP | INCY | 1.52% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.38% |
ALKERMES PLC | ALKS | 1.33% |
CRISPR THERAPEUTICS AG | CRSP | 1.25% |
INTRA-CELLULAR T | ITCI | 1.25% |
REVOLUTION MEDICINES INC | RVMD | 1.25% |
EXELIXIS, INC. | EXEL | 1.24% |
ARGENX SE - ADR | ARGX | 1.23% |
HALOZYME THERAPEUTICS INC | HALO | 1.21% |
VIKING THERAPEUTICS INC | VKTX | 1.20% |
BIONTECH SE-ADR | BNTX | 1.18% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.18% |
CYTOKINETICS INC | CYTK | 1.14% |
IONIS PHARMACEUTICALS, IN | IONS | 1.10% |
ROIVANT SCIENCES LTD | ROIV | 1.07% |
MEDPACE HOLDINGS | MEDP | 1.07% |
AVIDITY BIOSCIENCES INC | RNA | 1.06% |
BLUEPRINT MEDICI | BPMC | 1.05% |
ULTRAGENYX PHARM | RARE | 1.02% |
CRINETICS PHARMACEUTICALS | CRNX | 0.95% |
AXSOME THERAPEUT | AXSM | 0.88% |
APELLIS PHARMACE | APLS | 0.88% |
TG THERAPEUTICS | TGTX | 0.87% |
BRIDGEBIO PHARMA INC | BBIO | 0.86% |
DYNE THERAPEUTICS INC | DYN | 0.82% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.80% |
AMICUS THERAPEUTICS INC | FOLD | 0.80% |
GUARDANT HEALTH INC | GH | 0.78% |
TWIST BIOSCIENCE CORP | TWST | 0.78% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.72% |
INTELLIA THERAPE | NTLA | 0.72% |
NUVALENT INC-A | NUVL | 0.71% |
PTC THERAPEUTICS | PTCT | 0.69% |
SPRINGWORKS THERAPEUTICS | SWTX | 0.67% |
NOVAVAX INC | NVAX | 0.67% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.65% |
RECURSION PHARMACEUTICALS | RXRX | 0.63% |
IMMUNOVANT INC | IMVT | 0.62% |
DYNAVAX TECHNOLOGY | DVAX | 0.57% |
MADRIGAL PHARMAC | MDGL | 0.55% |
BEAM THERAPEUTICS INC | BEAM | 0.54% |
ARDELYX INC | ARDX | 0.52% |
KRYSTAL BIOTECH INC | KRYS | 0.50% |
AKERO THERAPEUTICS INC | AKRO | 0.44% |
IRONWOOD PHARMAC | IRWD | 0.35% |
SAGE THERAPEUTIC | SAGE | 0.30% |
Other (Cash, derivatives and other liabilities) | 0.26% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.